glaxosmithkline consumer healthcare

Study says nicotine patches effective without direct counseling

Nearly 20 percent of smokers using an over-the-counter nicotine patch in a new study were able to quit smoking entirely after six weeks, compared to only 7 percent of smokers using a dummy patch. Each group reported only mild side effects from patch use, like rashes or insomnia. None of the smokers received any direct instruction on how to use the patch or got behavioral counseling to help them quit smoking, which suggests that nicotine patches used in an over-the-counter manner can be safe and effective, say the study authors. The study was supported by GlaxoSmithKline Consumer Healthcare, which markets the NicoDerm CQ patch.

Feds approve nicotine lozenges

The U.S. Food and Drug Administration has approved a nicotine throat lozenge meant to help smokers kick the habit. The sweets will be sold in stores alongside similar gums and patches. Maker GlaxoSmithKilne says the over-the-counter lozenges will come in two strengths to provide smokers with a source of nicotine that helps them avoid cigarette cravings and withdrawal symptoms while they try to quit.